Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 256,462 shares, an increase of 71.9% from the May 31st total of 149,174 shares. Based on an average daily volume of 100,836 shares, the short-interest ratio is presently 2.5 days. Currently, 2.2% of the company’s shares are short sold.
Wall Street Analyst Weigh In
TNON has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Tenon Medical in a research note on Monday, April 20th. Alliance Global Partners reaffirmed a “buy” rating on shares of Tenon Medical in a research note on Wednesday, May 13th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold”.
Read Our Latest Analysis on TNON
Tenon Medical Stock Performance
Tenon Medical (NASDAQ:TNON – Get Free Report) last released its quarterly earnings data on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.01). The firm had revenue of $1.38 million for the quarter, compared to analysts’ expectations of $1.30 million. Tenon Medical had a negative return on equity of 907.60% and a negative net margin of 270.09%.
Hedge Funds Weigh In On Tenon Medical
Institutional investors have recently made changes to their positions in the company. DRW Securities LLC purchased a new stake in Tenon Medical in the fourth quarter worth about $98,000. Geode Capital Management LLC increased its position in Tenon Medical by 34.6% during the 4th quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock valued at $63,000 after purchasing an additional 17,137 shares during the period. Finally, Jane Street Group LLC purchased a new position in Tenon Medical during the 1st quarter valued at about $29,000. Hedge funds and other institutional investors own 22.74% of the company’s stock.
About Tenon Medical
Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.
Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.
Featured Articles
- Five stocks we like better than Tenon Medical
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
